Clinical Trial Update: Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for hypofractionated radiation therapy in Stage 0 to IIB breast cancer have been completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: University of Utah | Conditions: Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-02-06